TIG Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
TIG Advisors's DAWN Position: Q2 2026 in Review
TIG Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 613,918 shares — an estimated $13.2M sold.
TIG Advisors first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $13.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- TIG Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- TIG Advisors sold 613,918 Day One Biopharmaceuticals shares in Q2 2026, an estimated $13.2M.
- TIG Advisors first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
- TIG Advisors's Day One Biopharmaceuticals position peaked at $13.2M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on TIG Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.